Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk - Prabadin Corp

https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk

Health

August 29, 2025

By AdminPrabadin - 1 day ago

0

An international BMJ panel recommended broader use of SGLT-2 inhibitors and GLP-1 receptor agonists.

administrator